Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 14.1 Exhibit 14.1
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 107 Exhibit 107
Associated filings
- 21 Dec 22 RW Registration withdrawal request
- 2 Jun 22 F-1/A Registration statement (foreign) (amended)
- 10 May 22 FWP Free writing prospectus
- 9 May 22 F-1/A Registration statement (foreign) (amended)
- 25 Apr 22 F-1/A Registration statement (foreign) (amended)
- 14 Apr 22 F-1/A Registration statement (foreign) (amended)
- 6 Apr 22 F-1/A Registration statement (foreign) (amended)
- 23 Mar 22 F-1/A Registration statement (foreign) (amended)
-
18 Feb 22 F-1 Registration statement (foreign)
AGNPF similar filings
Filing view
External links
Exhibit 21.1
SUBSIDIARIES OF ALGERNON PHARMACEUTICALS INC.
The following is a list of all the subsidiaries of the Company and the corresponding jurisdiction of incorporation or organization of each. All subsidiaries of the Company are directly or indirectly owned by the Company.
Name of Subsidiary | Place of | Ownership |
Nash Pharmaceuticals Inc. | British Columbia, Canada | 100% |
Algernon Research PTY Ltd. | Australia | 100% (1) |
Notes:
(1) Algernon Research PTY Ltd. is a wholly-owned subsidiary of Nash Pharmaceuticals Inc.